Lanton Law
Home
About
Practice Areas
Legal Services
Lobbying
Blog
Contact
Lanton Law
Home
About
Practice Areas
Legal Services
Lobbying
Blog
Contact

Lanton Law Blog

Learn about the latest trends and activities through our blog posts.

Lanton Law Quoted in Pharmacy Times Article "FDA Approves First Nonprescription Daily Birth Control Pill"

Lanton Law was quoted in the Pharmacy Times article titled “FDA Approves First Nonprescription Daily Birth Control Pill.” The article can be viewed here.

FDA, healthcareRon LantonJuly 14, 2023FDA, Birth control, Opill, Perrigo, oral contraceptive
0 Likes
Previous

Lanton Law Lobbies on Beacon Hill in Boston, Massachusetts for Pharmacy Issues

lobbyist, healthcare, health system, pharmaceuticals, pharmacyRon LantonJuly 14, 2023Beacon Hill, Boston, legislation, legislative, Massachusetts statehouse, pharmacy, health promotion screening, Pharmacy Benefit Manager Transparency Act
Next

Latest Mifepristone Legal Debates Raise More Questions, Confusion for Health Care Professionals

healthcare, U.S. Supreme CourtRon LantonMay 9, 2023U.S. Supreme Court, mifepristone, Dobbs v. Jackson Women’s Health